Remove 2016 Remove Debt Financing Remove Market Capitalization Remove Marketability
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

2022 drivers and headwinds Choppy access to capital markets and financing to fund ongoing operations Many life sciences companies faced challenges raising money in the capital markets in 2022. Let’s dig in.

article thumbnail

The Corporate Tax Burden: Facts and Fiction

Musings on Markets

For instance, the 2017 US tax reform act, in addition to lowering the corporate tax rate, also changed the way that foreign income to US companies was taxed and put limits on the tax deductibility of debt. and the cash tax rate by 2.75%.